The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle by Zhang, Xiuping & Qu, Shaogang
The Accessibility in the External Part of the TM5 of the
Glutamate Transporter EAAT1 Is Conformationally
Sensitive during the Transport Cycle
Xiuping Zhang
1, Shaogang Qu
2*
1China-America Cancer Research Institute, Guangdong Medical College, Dongguan, Guangdong, China, 2Department of Immunology, Southern Medical University,
Guangzhou, Guangdong, China
Abstract
Background: Excitatory amino acid transporter 1 (EAAT1) is a glutamate transporter which is a key element in the
termination of the synaptic actions of glutamate. It serves to keep the extracellular glutamate concentration below
neurotoxic level. However the functional significance and the change of accessibility of residues in transmembrane domain
(TM) 5 of the EAAT1 are not clear yet.
Methodology/Principal Findings: We used cysteine mutagenesis with treatments with membrane-impermeable sulfhydryl
reagent MTSET [(2-trimethylammonium) methanethiosulfonate] to investigate the change of accessibility of TM5. Cysteine
mutants were introduced from position 291 to 300 of the cysteine-less version of EAAT1. We checked the activity and kinetic
parameters of the mutants before and after treatments with MTSET, furthermore we analyzed the effect of the substrate and
blocker on the inhibition of the cysteine mutants by MTSET. Inhibition of transport by MTSET was observed in the mutants
L296C, I297C and G299C, while the activity of K300C got higher after exposure to MTSET. Vmax of L296C and G299C got
lower while that of K300C got higher after treated by MTSET. The L296C, G299C, K300C single cysteine mutants showed a
conformationally sensitive reactivity pattern. The sensitivity of L296C to MTSET was potentiated by glutamate and TBOA,but
the sensitivity of G299C to MTSET was potentiated only by TBOA.
Conclusions/Significance: All these facts suggest that the accessibility of some positions of the external part of the TM5 is
conformationally sensitive during the transport cycle. Our results indicate that some residues of TM5 take part in the
transport pathway during the transport cycle.
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Introduction
Glutamate is the major excitatory neurotransmitter in the
central nervous system. The glutamate/neutral amino acid
transporter family, also known as solute carrier family 1 (SLC1),
includes many prokaryotic transporters as well as five excitatory
amino acid transporters (EAAT) and two Na
+-dependent neutral
amino acid transporters. GLAST/EAAT1 [1,2] and GLT1/
EAAT2 [3] were cloned from rat while EAAC1/EAAT3 [4] was
cloned from rabbit. EAAT4 [5] and EAAT5 [6] were both cloned
from human. EAATs are the key elements in the termination of
the synaptic actions of glutamate by uptaking glutamate from the
synaptic cleft into cytoplasm [1,2,7–9]. So they serve to keep the
extracellular glutamate concentration below neurotoxic level.
Glutamate transporters have a non-conventional topology. The
amino-terminal half consists of six transmembrane domain
segments, and the significantly more conserved carboxy-terminal
half consists of two re-entrant loops and two transmembrane
domains (TM7 and TM8) [10–12]. In addition, many residues of
the carboxy-terminal half were implicated to be important for
substrate and co-substrate binding and translocation [13,14,15–
22]. A high-resolution crystal structure of a glutamate transporter
homologue, GltPh, from the archeon Pyrococcus horikoshii was
published [23], and it confirms and refines the topology as
determined by functional studies [10,11,24,25]. Moreover, the
equivalent residues from the eukaryotic glutamate transporters,
which are involved in potassium binding [13,15,26], sodium
specificity [14,16,21,22], and the ligand of the c-carboxyl of
glutamate [17], are located at the binding pocket of GltPh.
Therefore, the GltPh structure appears to be a good model for the
study of its eukaryotic counterparts. It forms a trimer with a
permeation pathway through each of the monomers. For the
bacterial glutamate transporter and the neuronal glutamate
transporter each monomer functions independently [27–31].
The first six transmembrane segments, which are less conserved,
form a distorted ‘amino-terminal cylinder’ and provide all inter-
protomer contacts, whereas the conserved transmembrane
segments TM7 and TM8, together with hairpins HP1 and HP2,
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transporter and HP1 is the internal one. They alternately open so
that the substrate-binding site can be accessed from extracellular
or intracellular solution respectively [23,32–35].
The trimeric interface of the glutamate transporter involving
TMs 2, 4, and 5 is unchanged during transport [27]. To assess the
functional significance of residues in TM5 of the cysteine-less
version of EAAT1 (CL-EAAT1, in which the endogenous
cysteines were replaced by serine or alanine, so that the interaction
between the sulfhydryl reagents and endogenous cysteines is
abolished), cysteine mutants were introduced from position 291 to
300, the end half of the Cysteine-less EAAT1 (Fig. 1). We checked
the activity and kinetic parameters of the mutants before and after
treatments with the membrane-impermeable sulfhydryl reagent
MTSET [(2-trimethylammonium) methanethiosulfonate]; further-
more we also analyzed the effect of the substrate and blocker on
the inhibition of cysteine mutants by MTSET. Our results indicate
that the activity of some cysteine mutants was inhibited by
MTSET, and glutamate and the glutamate’s blocker, non-
transportable glutamate analogue D,L-threo-b-benzyloxyaspartate
(TBOA) can modulate this inhibitive effect. The data provides
evidence that some residues of TM5 take part in the transport
pathway during the transport cycle.
Results
Cysteine-scanning mutagenesis and impact of MTSET
and MTSEA
Since the majority of TM5 is buried under the interior of the
transporter, we only chose the end of the TM5, from position 291
to 300 to analyze the sensitivity of single cysteine mutants to
MTSET. Cysteines were introduced one at a time into each of
these positions of the Cysteine-less EAAT1. Cysteine-less EAAT1
has similar transport properties comparing with wild-type EAAT1,
and it’s an excellent background in which to introduce single
cysteine mutants to study the function of the residues [36]. After
transient expression of the Cysteine-less EAAT1 and the cysteine
mutants in HeLa cells, transport of D-[
3H]aspartate was
measured. The activity of the cysteine mutants at these positions
ranged from 18.1 to 92.6% of the Cysteine-less EAAT1 (Fig. 2).
We expressed each mutant in HeLa cells and then measured the
accumulation of radiolabeled D-aspartate before and after
exposure to the membrane-impermeable sulfhydryl reagent
MTSET. Transport by L296C, I297C, G299C single cysteine
mutants was inhibited by 1.0 mM MTSET, while the activity of
K300C got higher after exposure to MTSET (Fig. 3A). The
sensitivity of L296C and G299C to MTSET was far greater than
that of I297C, and the activity of these three mutants was inhibited
by MTSET in a dose-dependent manner (Fig. 3B). An almost full
inhibition of activity of L296C and G299C was observed when
MTSET concentration was increased to 2.0 mM (Fig. 3B). With
regard to the impact of the impermeant sulfhydryl reagent
MTSET on activity, the end half of the TM5 can be divided in
two regions: 1) the internal region, including from position 291 to
295, where none of the cysteine mutants are sensitive to MTSET;
and 2) the external region, from position 296 to 300, where the
mutants are impacted by MTSET with the exception of A298C
(Fig. 3A). This suggests that the introduced cysteines at the
external region are exposed from the extracellular side. Further
more we also checked the cysteine mutants of the internal region
with the membrane-permeable sulfhydryl reagent MTSEA [(2-
Figure 1. Structural model of Gltph. The figure was prepared with
the SPDB Viewer using the coordinates from PDB code 1XFH. The end
of the TM5, from position 291 to 300, is colored green.
doi:10.1371/journal.pone.0030961.g001
Figure 2. Transport activity of single cysteine mutants of TM5.
The Cysteine-less EAAT1 and the TM5 mutants were expressed in HeLa
cells. D-[
3H]-aspartate uptake was measured as described under
‘‘Materials and methods’’. Data are given as a percentage of Cysteine-
less EAAT1 transport activity and are mean6S.E. of 3 to 4 experiments
each performed in triplicates.
doi:10.1371/journal.pone.0030961.g002
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from the intracellular side. MTSEA had no inhibitory effect on the
activity of the cysteine mutants of the internal region (Fig. 3C), so
the internal region isn’t exposed from the intracellular side.
The biotinylation reagent only modifies proteins at the plasma
membrane [37]. Surface biotinylation experiments showed that in
the total samples of Cysteine-less EAAT1 and mutants, the major
band has a mobility of 65–70 kDa, which represents mature
monomeric forms of the transporter. The slower moving bands
apparently represent dimeric/aggregate forms of the transporter
(Fig. 4) [37,38]. In the case of the biotinylated samples of Cysteine-
less EAAT1 and mutants, the major band with mobility of 65–
70 kDa were observed (Fig. 4). L296C and G299C were present
on the plasma membrane at similar levels of Cysteine-less EAAT1
(Fig. 4). Scanning of the bands from the biotinylated samples from
three different experiments indicates that intensity of the 65–
70 kDa bands of I297C and K300C is statistically different from
that of Cysteine-less EAAT1 (one-way ANOVA with post-hoc
multiple comparison test, p,0.01). The percentage values of
Cysteine-less EAAT1 are 78.2611.6, 23.766.4, 94.865.3 and
11.362.5 for L296C, I297C, G299C and K300C, respectively.
This experiment indicated that the lack of activity of I297C and
K300C was due to defective targeting of these mutant transporters
to the plasma membrane (Fig. 4). There are no transporter bands
in the lanes labeled SK, which illustrated the specificity of the
antibody (Fig. 4).
The kinetic parameters of glutamate were examined. In the
presence or absence of MTSET, there is no significance difference
between the Km values for L-glutamate of each mutant and that of
Cysteine-less EAAT1 (Table 1). Furthermore the Km values of
Cysteine-less EAAT1 and mutants were similar in the presence
and absence of MTSET (Table 1). In contrast, after exposure to
MTSET L296C and G299C have a significantly lower Vmax while
K300C has a significantly higher one (Table 1).
Effect of transporter ligands on impact of TM5 single
mutants by MTSET
For the cysteine mutants which are sensitive to MTSET, we
checked the effects of transporter ligands on the sensitivity of single
cysteine mutants to MTSET. From these experiments we tried to
investigate the conformational change of TM5 in different stage of
the transport cycle. The experiments were done in two stages. 1.
Preincubation of HeLa cells expressing the single cysteine mutants
with MTSET was done under various conditions reflecting
different stages of the transporter (6Na, 6substrate, 6blocker).
2. After washing away the MTSET and substrate/blocker, the
impact of the treatment was determined by measurement of
transport.
Figure 3. Effect of MTSET and MTSEA on uptake activity of
single cysteine mutants of TM5. HeLa cells expressing single
cysteine mutants or Cysteine-less EAAT1, were preincubated in NaCl-
containing medium with sulfhydryl reagent for 5 min at room
temperature, washed twice with choline chloride-containing solution,
and subsequently D-[
3H]-aspartate transport was assayed. Data
represent percentage of the remaining uptake activity after incubation
with sulfhydryl reagent relative to values obtained in the absence of
sulfhydryl reagent. Values represent the mean 6 S.E. of at least three
separate experiments each performed in triplicate. (A) Effect of MTSET
on transport activity of single cysteine mutants of TM5. The
concentration of MTSET used in this study was 1.0 mM. (B) Effect of
different concentrations of MTSET on transport activity of L296C, I297C
and G299C. (C) Effect of MTSEA on transport activity of single cysteine
mutants of TM5. The concentration of MTSEA used in this study was
2.5 mM.
doi:10.1371/journal.pone.0030961.g003
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concentration of MTSET respectively to keep the transport
activity of mutants around 60% of the control so that we could
investigate the effects of the transporter substrate and blocker on
the sensitivity of single cysteine mutants to MTSET (Fig. 5A, B
and C). For I297C, the substrate L-glutamate and the glutamate’s
blocker TBOA had no effect on the inhibition of transport of
I297C by MTSET, and we got the same result when NaCl was
substituted by KCl (Fig. 5B). MTSET caused a stimulation of
transport activity of K300C (201.2612.1% of control, n=3)
(Fig. 3A). TBOA is expected to ‘‘lock’’ EAAT1 in an outward-
facing conformation, increases the proportion of protein trapped
in an outward-facing conformation, thereby increasing the
aqueous accessibility from the extracellular side. Indeed, the
inhibition of L296C and G299C by MTSET was significantly
increased in the presence of TBOA (Fig. 5A and C). 36.762.3%
and 40.663.0% activity remained after treatment with MTSET in
TBOA for L296C and G299C respectively (Fig. 5A and C), while
61.663.2% and 64.765.9% activity remained after treatment
with MTSET in NaCl for the two mutants respectively (n=3)
(Fig. 5A and C). When the sodium-containing medium was either
supplemented with glutamate or replaced by potassium, it would
increase the proportion of inward-facing transporters. In the
presence of L-glutamate, a small but significant potentiation of the
inhibition by MTSET was observed with L296C (46.964.1% of
control in L-glutamate compared with 61.663.2% of control in
NaCl, n=3) (Fig. 5A), and the same was true for potassium
(49.262.7% of control in KCl compared with 61.663.2% of
control in NaCl, n=3) (Fig. 5A). The potentiation was not
observed with c-aminobutyric acid (GABA), which are not
substrates of EAAT1 (Fig. 5A), so it demonstrates the specificity
of this effect by L-glutamate. On the other hand, L-glutamate did
not have a significant effect on the inhibition of G299C by
MTSET (Fig. 5C). The enhancement of K300C by MTSET in
NaCl (255.4610.5% of control, n=3) was significantly decreased
in the presence of L-glutamate, potassium and TBOA
(187.267.8%, 176.165.1% and 131.366.9% of control respec-
tively, n=3) (Fig. 5D). Our results indicate that the accessibility of
some positions of the end of the TM5 is conformationally sensitive.
Discussion
The trimeric interface of the glutamate transporter involving
TMs 2, 4, and 5 is rigid during transport [27]. The 3–4 loop of an
Figure 4. Cell surface biotinylation of Cysteine-less EAAT1 and mutants. HeLa cells, expressing Cysteine-less EAAT1 and the four indicated
mutants, as well as HeLa cells transfected with the vector alone (SK), were biotinylated and processed as described in the Materials and Methods. The
six left lanes show the total samples, and the six right lanes show the biotinylated samples. All samples were separated on the same SDS gel,
transferred to nitrocellulose, and probed with the antibody to EAAT1. The positions of the molecular mass standards (in kDa) are indicated on the
right. The experiment was repeated three times and a similar result was obtained. The result is representative of three independent experiments.
doi:10.1371/journal.pone.0030961.g004
Table 1. Kinetic parameters of CL-EAAT1 and single cysteine
mutants.
Vmax Km MTSET
Vmax Km
CL-EAAT1 100 39.364.6 94.866.4 43.562.5
L296C 30.264.6 35.865.2 12.462.1* 37.964.7
I297C 28.162.7 42.764.1 22.764.3 41.263.6
G299C 25.661.9 36.962.6 11.962.8* 39.562.8
K300C 16.862.1 34.564.3 26.463.5* 38.463.2
Km (mM) and Vmax values were calculated for CL-EAAT1 and single cysteine
mutants with and without MTSET preincubation. Vmax is expressed as a
percentage of untreated CL-EAAT1. * denotes values that are significantly
different after MTSET treatment. Values represent the mean 6 S.E. of three
independent experiments done in triplicate.
doi:10.1371/journal.pone.0030961.t001
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during the transport cycle, and cleaving the 3–4 loop results in the
inactivation of the transporter [39]. Previously we have analyzed
the proximity and functional significance of residues in TM5 and
TM8 of the cysteine-less version of GLT-1. TM5 is in close
proximity to TM8 in the glutamate transporter, and the spatial
relationship between these domains is altered during transport
[40]. From these findings we presume that TM5 maybe also take
part in the substrate transport.
The introduced cysteines can react, through their sulfhydryl
group, with a variety of sulfhydryl reagents. These reagents react
in an aqueous environment since the sulfhydryl-group of the
cysteine residue must be in its ionized form (Cysteine-S
2). This
reaction can lead to variable degrees of loss of function of the
membrane protein, depending on the location of the cysteine and
the importance of that position to the function of the protein.
These sulfhydryl reagents react with the thiolate anion, and
therefore, their reactivity appears to reflect accessibility of the
introduced cysteine residues from the aqueous medium. These
reagents include various MTS (methanethiosulfonate, CH3-SO2-
S-R) reagents that differ in their size and charge. Some MTS
reagents are membrane-permeable (MTSEA) and some are
membrane-impermeable (MTSET).This difference in charge and
bulk between the sulfhydryl reagents allows the investigation of
specific positions changed into cysteine and allows the study of
whether it is exposed from the extracellular or intracellular side.
When the amino acid residues 291–300 of the Cysteine-less
EAAT1, located in the end of the TM5, all the mutants retain
some level transport activity (Fig. 2). Three of ten of the mutants
are inhibited by the membrane-impermeable sulfhydryl reagent
MTSET (Fig. 3A). This suggests that these cysteines are exposed
from the extracellular side. However, the end of the TM5 does not
appear to form a completely open structure, because there are
differences in sensitivity to MTSET between the different mutants
(Fig. 3A). None of the cysteines introduced from position 291 to
295 are sensitive to MTSET, so these positions are not exposed
from the external aqueous medium (Fig. 3A). MTSEA also had no
inhibitory effect on the activity of these cysteine mutants (Fig. 3C).
Therefore this region isn’t exposed from the intracellular side.
After exposure to MTSET the Km values of the mutants have no
change but Vmax of L296C and G299C reduces, Vmax of K300C
increases (Table 1). This data suggest that the reaction of L296C,
G299C and MTSET rescinds the transport activity while the
reaction of K300C and MTSET increases the transport activity.
The reaction of the introduced cysteines and MTSET doesn’t
change the apparent affinity for glutamate, which means that the
interaction of the mutants with L-glutamate isn’t impaired, even
though HeLa cells expressing mutants were treated by MTSET.
TBOA increases the proportion of protein trapped in an
outward-facing conformation,thereby increasing the aqueous
accessibility from the extracellular side. Indeed, the inhibition of
L296C and G299C by MTSET was significantly increased in the
Figure 5. Effect of the composition of the external medium on
the inhibition of single cysteine mutants by MTSET. HeLa cells
expressing the single cysteine mutants L296C (A), I297C (B), G299C (C)o r
K300C (D), were preincubated for 5 min in the presence or absence of 0.2
(A), 1.0 (B), 0.6 (C)o r0 . 0 1( D) mM MTSET. The indicated preincubation
solutions contained NaCl, NaCl+1mM L-glutamate, NaCl+20 mMT B O A ,
NaCl+1mM GABA, KCl, choline chloride. Subsequently the cells were
washedandD-[
3H]-aspartate transport was measured as described under
‘‘Materials and methods’’. Values are given as a percentage of control
(preincubation without MTSET) and represent the mean 6 S.E. of at least
three different experiments done in triplicate.
doi:10.1371/journal.pone.0030961.g005
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for this potentiation. One of the possibilities is that TBOA
increases the aqueous accessibility of these positions from the
extracellular aqueous medium. The other one is that after TBOA
binding to the pocket, the external gate opens to the extracellular
side which exposes the transport pathway to the extracellular
solution [32,41], so these positions might be expose to the
transport pathway. Or a combination of these first two possibilities
may be occurring. When the sodium-containing medium was
either supplemented with glutamate or replaced by potassium, it
would promote the formation of the inward-facing conformation
withtheexternalgateclosed.InthepresenceofL-glutamate,a small
but significant potentiation of the inhibition by MTSET was
observed with L296C (Fig. 5A). On the other hand,L-glutamate did
not have a significant effect on the inhibition of G299C by MTSET
(Fig. 5C). These results suggest that G299C indeed is both exposed
to the extracellular aqueous medium and the transport pathway in
the presence of TBOA which keeps the external gate opening, so
Gly-299 contact with the transport pathway. In this situation the
extent of the exposure of G299C is maximal. In the presence of L-
glutamate which keep the external gate closed G299C can’t
communicate the extracellular medium via the transport pathway,
onlydirectly exposes to the extracellular side, so the accessibility was
decreased under conditions favoring the inward facing conforma-
tion of the transporter comparing with that in the outward facing
conformation. In our earlier studies about the cysteine mutant
G297C of GLT-1 (GLT-1 residue Gly-297 corresponds to Gly-299
of EAAT1) we also got the same results for the accessibility under
different conditions [40]. As for L296C, L-glutamate and TBOA
both cause a potentiation of the inhibition of transport by MTSET,
but TBOA cause a potentiation to a higher extent (Fig. 5A). L296C
might also be both exposed to the extracellular aqueous medium
and the transport pathway in the presence of TBOA. In the
presence of L-glutamate L296C can’t communicate with the
extracellular medium via the transport pathway, is only directly
exposed to the extracellular side, so the accessibility was decreased
compared with that in the presence of TBOA. However the
transport of the substrate causes L296C to be much more directly
exposed to the extracellular side, so the gap of the accessibility of
L296C between in the presence of TBOA and L-glutamate was
smaller than that of G299C.
Cysteines react, through their sulfhydryl group, with MTSET.
Thisreactioncanlead tovariabledegreesofinhibition offunctionof
the membrane protein. However, in contrast to other mutants,
MTSET increase the transport activity of K300C (Fig. 3A). It
therefore appears that the reaction between K300C and MTSET
can result in a complex conformational change, and this change is
better for the substrate transport. The conformational change may
include the compensatory shifting of other parts of the transporter.
Now it is not clear what the nature of this conformational change is.
The reactivity at this position was conformationally sensitive
(Fig.5D).TheenhancementofK300CbyMTSETwassignificantly
decreased in the presence of L-glutamate and TBOA (Fig. 5D).
All these facts suggest that the accessibility of some positions of
the external part of the TM5 is conformationally sensitive during
the transport cycle. Our results indicate that some residues of TM5
take part in the transport pathway during the transport cycle.
Materials and Methods
Materials
D-[
3H]-aspartate (11.3 Ci/mmol) and L-[
3H]-glutamate (49.9
Ci/mmol) were purchased from PerkinElmer Inc. DL-TBOA was
purchased from Tocris Bioscience. L-glutamate was purchased
from Sigma. MTSET was purchased from Biotium Inc. DOTAP
was purchased from Roche Molecular Biochemicals. DMEM,
FCS, Trypsin(0.25%)-EDTA were purchased from Thermo Fisher
Scientific Inc. Restriction enzymes were purchased from New
England Biolabs. T4 Polynucleotide Kinase, T4 DNA Kinase, T4
DNA Polymerase, and T4 DNA Ligase were purchased from
Roche. All other reagents were analytical grade.
Generation and Subcloning of Mutants
The Cysteine-less EAAT1 in the vector pBluescript SK(–)
(Stratagene) will be used as a parent for site-directed mutagenesis.
The parent DNA was used to transform Escherichia coli CJ236
(dut–, ung–). From one of the transformants, single-stranded
uracil-containing DNA was isolated upon growth in uridine-
containing medium according to the standard protocol from
Stratagene using helper phage R408. This yields the sense strand,
and consequently mutagenic primers were designed to be
antisense. Restriction enzymes BsrGI and BstEII were used to
subclone the mutations into the construct containing Cysteine-less
EAAT1 in the vector pBluescript SK(–). The subcloned DNA
fragments were sequenced on both strands between the two
restriction sites noted.
Cell Growth and Expression
HeLa cancer cell line was purchased from ATCC (Manassas,
VA). HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum (FCS),
200 units/ml penicillin, 200 mg/ml streptomycin, and 2 mM
glutamine. Heterologous expression of the wild type and mutant
transporters was done as follows: HeLa cells plated on 24-well
plates were infected with recombinant vaccinia/T7 virus vTF
[42], and transfected with plasmid DNA encoding Cysteine-less
EAAT1, mutants, or the vector pBluescript SK– alone using the
transfection reagent DOTAP, as described [43]. Cells were
incubated at 37uC for 16–20 hours.
Cell Surface Biotinylation
After expression of transporters in HeLa cells (in 12-well plates),
the medium was aspirated and the cells were washed twice with
2 ml/well of phosphate-buffered saline (PBS) containing 0.1 mM
CaCl2 and 1 mM MgCl2 (PBS/CM). The cells were incubated on
ice in 500 ml of 1.5 mg/mL NHS-SS-biotin (Pierce, Inc., Rock-
ford, IL) in 20 mM HEPES, pH 9.0, 2 mM CaCl2, and 150 mM
NaCl for two successive 20-min incubations. After labeling, the
cells in each well were rinsed briefly with 1 ml of 100 mM glycine
in PBS/CM and incubated in the same solution for 20 min on ice
to quench unreacted NHS-SS-biotin. The cells were dissolved in
100 ml of lysis buffer consisting of 1% Triton X-100, 1% SDS,
150 mM NaCl, 5 mM EDTA, and 50 mM Tris-HCl (pH 7.5) by
gentle shaking on ice for approximately 1 h until the cells were
completely lysed, as assessed by light microscopy. The lysates from
each well were then diluted by the addition of 900 ml of lysis buffer
to reduce the concentration of SDS and clarified by centrifugation
for 10 min at 16000g at 4
oC. The biotinylated proteins were
recovered from the supernatant solution by adding 100 mlo f
streptavidin-agarose beads (Pierce, Inc., Rockford, IL) and
incubating 1 hour at 4
oC with gentle agitation. The beads were
washed three times with 1 ml of lysis buffer, twice with high-salt
lysis buffer (lysis buffer containing 500 mM NaCl and only 0.1%
Triton X-100), and once with 50 mM Tris-HCl (pH 7.5). The
biotinylated proteins were finally eluted from the beads in 100 ml
of SDS buffer according to the manufacturer’s recommendation at
60uC for 10 min, 3 min on ice and then were centrifuged. Total
samples were obtained by washing cells expressing Cysteine-less
The Accessibility of the TM5 of EAAT1
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phosphate-buffered saline/CM, followed by lysis in SDS sample
buffer, heating for 3 min at 60uC, and centrifugation. Samples
were separated by SDS-polyacrylamide gel electrophoresis (10%
gel) and transferred to nitrocellulose. The EAAT1 protein was
detected with the antibody to EAAT1. Scanning and quantifica-
tion of bands on the developed films was done using a Fluor-S
TM
MultiImager scanner with MultiAnalyst software, both from
Bio-Rad.
Transport
Transport of radioactive D-[
3H]-aspartate or L-[
3H]-glutamate
was measured 16–20 hours post transfection. Plates were taken
out. Wells were washed once with 1 ml of the choline solution
(150 mM choline chloride, 5 mM KPi, pH 7.4, 0.5 mM MgSO4,
and 0.3 mM CaCl2). Each well was then incubated for 10 min at
room temperature with 200 ml of radioactive sodium uptake
solution (150 mM NaCl, 5 mM KPi, pH 7.4, 0.5 mM MgSO4,
and 0.3 mM CaCl2) which supplemented with 0.4 mCi of the
tritium-labeled substrate. Uptake was stopped after 10 min by
removing the transport solution and washing the cells twice in cold
sodium uptake solution. HeLa cells were lyzed with SDS, and
followed by scintillation counting.
Inhibition Studies with Sulfhydryl Reagent
Before the transport measurements, the cells adhering to 24-well
plates were washed with the choline solution. Each well was then
incubated at room temperature with 200 mL of the preincubation
medium containing MTSET or MTSEA (the different composi-
tions are indicated in the figure legends). After 5 min, the medium
was aspirated, and the cells were washed twice with 1 ml of the
choline solution. Subsequently, each well was then incubated for
10 min at room temperature with 200 ml of radioactive sodium
uptake solution. Then HeLa cells were lyzed with SDS, and
followed by scintillation counting. Each experiment was per-
formed at least three times. The concentration of MTSET chosen
in the different experiments was optimized according to the
mutants used.
Kinetics
HeLa cells expressing Cysteine-less EAAT1 or mutants were
measured for the ability to accumulate L-glutamate (200 mM;100
nM L-[
3H]-glutamate, 199.9 mM unlabeled L-glutamate) as a
function of time. Uptake kept linear for 10 min. HeLa cells were
preincubated for 5 min in the presence or absence of 1.0 mM
MTSET. Subsequently the cells were washed and incubated with
100 nM L-[
3H]-glutamate in final unlabeled L-glutamate
concentrations of 1, 5, 10, 50, 100, 250, 500 and 1000 mM for
10 min at room temperature. Then L-[
3H]-glutamate transport
was measured. Affinity constant (Km) and maximum velocity (Vmax)
were determined by the Michaelis-Menten equation using
KaleidaGraph (Synergy Software, Reading, PA). Vmax is expressed
as a percent of that of untreated Cysteine-less EAAT1.
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